CDKN2A and gastrin-producing neuroendocrine tumor: Although large deletions or amplifications are relatively rare, gastrinoma is characterized by amplification of the HER-2/neu proto-oncogene or chromosome 9q, deletion of the p16/MTS1 tumor suppressor gene or deletion of chromosome 3p [119].